Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.84 USD | +2.89% | +4.10% | -6.64% |
Apr. 02 | Voyager Therapeutics, Inc. Appoints Robin Swartz as Principal Accounting Officer | CI |
Apr. 02 | Voyager Therapeutics, Inc. Announces CFO Changes | CI |
Financials (USD)
Sales 2024 * | 38.84M | Sales 2025 * | 51.19M | Capitalization | 414M |
---|---|---|---|---|---|
Net income 2024 * | -98M | Net income 2025 * | -106M | EV / Sales 2024 * | 2.53 x |
Net cash position 2024 * | 316M | Net cash position 2025 * | 373M | EV / Sales 2025 * | 0.8 x |
P/E ratio 2024 * |
-4.24
x | P/E ratio 2025 * |
-4.34
x | Employees | 162 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.74% |
Latest transcript on Voyager Therapeutics, Inc.
1 day | +2.89% | ||
1 week | +4.10% | ||
Current month | -15.36% | ||
1 month | -25.24% | ||
3 months | +3.68% | ||
6 months | +20.49% | ||
Current year | -6.64% |
Managers | Title | Age | Since |
---|---|---|---|
Alfred Sandrock
CEO | Chief Executive Officer | 67 | 22-02-28 |
Michael Higgins
CHM | Chairman | 61 | 15-07-21 |
Director of Finance/CFO | 55 | 22-09-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Scangos
BRD | Director/Board Member | 76 | 23-05-08 |
James Geraghty
BRD | Director/Board Member | 70 | 13-12-31 |
Glenn F. Pierce
BRD | Director/Board Member | 68 | 17-01-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.67% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 7.88 | +3.41% | 74 374 |
24-04-26 | 7.62 | +2.70% | 479,915 |
24-04-25 | 7.42 | -1.98% | 522,452 |
24-04-24 | 7.57 | -1.05% | 312,899 |
24-04-23 | 7.65 | +1.06% | 372,355 |
Delayed Quote Nasdaq, April 29, 2024 at 10:57 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.64% | 414M | |
+1.99% | 42.75B | |
+47.81% | 41.61B | |
+12.07% | 41.34B | |
-12.36% | 26.59B | |
+8.27% | 25.49B | |
-23.45% | 18.12B | |
+30.45% | 12.24B | |
-2.14% | 11.76B | |
+8.37% | 11B |
- Stock Market
- Equities
- VYGR Stock